Skip to main content
Fig. 2 | Gut Pathogens

Fig. 2

From: The in vitro and ex vivo effect of Auranta 3001 in preventing Cryptosporidium hominis and Cryptosporidium parvum infection

Fig. 2

Effect of different concentrations of Auranta 3001 on Cryptosporidium invasiveness in primary bovine cells. a Primary bovine cells exposed to different concentrations of Auranta 3001 for 1 h prior to infection. b Cryptosporidium oocysts exposed to different concentrations of Auranta 3001 for 1 h prior to infection. c Auranta 3001 present in the medium during infection. d Transepithelial electrical resistance (TEER) values of non-treated cells and cells treated with Auranta 3001. Asterisks indicate significant differences (*p < 0.05; **p < 0.01; ***p < 0.001). Error bars represent the standard deviation of means from three different experiments. G1, Cryptosporidium hominis; G2, Cryptosporidium parvum; CyD, cytochalasin D

Back to article page

Gut Pathogens

ISSN: 1757-4749